Navigation Links
Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe
Date:11/19/2009

MALVERN, Pa. and WALTHAM, Mass., Nov. 19 /PRNewswire/ -- Arlington Medical Resources (AMR) and Decision Resources find that the leading driver of antibiotic selection in nosocomial pneumonia in Europe is broad-spectrum activity against gram-positive and gram-negative pathogens. Due to the variety of organisms that can cause nosocomial pneumonia, surveyed European physicians reveal that they look primarily for agents that provide appropriate coverage against common pathogens, particularly for empiric therapy.

"Nosocomial pneumonia is an extremely important indication in Europe because it is a significant cause of morbidity and mortality," stated Decision Resources Analyst Lisa Arias. "Prescribing for nosocomial pneumonia is heavily driven by the need for timely, effective empiric therapy, and European specialists cite Pseudomonas and MRSA as the most concerning pathogens in nosocomial pneumonia."

In the new report entitled Hospital Anti-Infectives Insight Series: Nosocomial Pneumonia, surveyed European infectious disease specialists were highly receptive toward new antibiotics in late-stage development, including the two next-generation anti-MRSA cephalosporins (Johnson & Johnson/Basilea's ceftobiprole and Forest/AstraZeneca's ceftaroline) and the novel anti-MRSA lipoglycopeptide telavancin (Astellas/Theravance/Takeda's Vibativ). European physicians indicate that these therapies could be used in empiric therapy for nosocomial pneumonia when the pathogen is unknown and MRSA infection is suspected. Because European specialists foresee an increase in the incidence of MRSA nosocomial pneumonia in the next five years, these therapies may become useful additions to the antibiotic armamentarium, offering much needed novel treatment options for MRSA nosocomial pneumonia.

"There are limited therapeutic options to target resistant pathogens in nosocomial pneumonia, so there is high unmet need for new, effect
'/>"/>

SOURCE Decision Resources; Arlington Medical Resources
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. NexBio(R) Demonstrates DAS181 (Fludase(R)*), a Broad-Spectrum Drug Candidate, Inhibits Influenza Viral Infection in Human Lung Tissue
2. Anacor Achieves Milestone from GSK for Boron-Based Systemic Antibacterial Product Candidate
3. Rib-X Pharmaceuticals to Present at Cambridge Healthtech Institutes 2nd Annual Challenge of Antibacterial Development Conference
4. GlaxoSmithKline Awarded U.S. Department of Defense Contract to Pursue Novel Antibacterial Research Program
5. Promega and SwitchGear Publish Findings from Combined Technologies that Correlate Binding Events and Transcriptional Activity
6. Monetary gain and high-risk tactics stimulate activity in the brain
7. NexBio(R) Presents Data Showing Anti-Asthma Activity of DAS181 (Fludase(R)*) at ACAAI 2009
8. Rib-X Pharmaceuticals Antibiotic Drug Discovery Platform Discovers Novel Compounds with Activity Against Key Multiple Drug Resistant Gram-negative Bacteria
9. Data Published in Cell Stem Cell Demonstrates Potent Anti-Cancer Activity for OncoMed Pharmaceuticals Lead Antibody
10. Celator(R) Pharmaceuticals Presents Data on the Activity of CPX-351 Against Leukemia at the European Hematology Association Congress
11. SemBioSys plant-derived Apo AI(Milano) demonstrates encouraging biologic activity in seven preclinical models
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... RESEARCH TRIANGLE PARK, N.C., USA (PRWEB) May 17, 2013 ...     Green Globes Certified for sustainability , ... drought and insect pressures , Syngenta ... grand opening celebration today at the company’s RTP Innovation ... Crop Lab allows company researchers to simulate any agricultural ...
(Date:5/17/2013)... PALO ALTO, Calif. , May 17, 2013 ... that it has achieved 50% enrollment of the ... trial to evaluate the safety and preliminary efficacy ... Progenitor Cells) therapy for Knee Osteoarthritis (KOA). To ... Effect (SAE) reported. The Phase I ...
(Date:5/17/2013)... May 17, 2013 /PRNewswire-iReach/ -- Aridis is pleased ... with Switzerland -based Kenta Biotech ... monoclonal antibody (mAb) products, and technologies. This asset ... for treatment of infections by common pathogens including ... , Pseudomonas aeruginosa , Acinetobacter baumannii ...
(Date:5/17/2013)... (PRWEB) May 17, 2013 Men’s skin is ... La-roche Posay ) and has been known to react ... some men may be far from puberty, other acne causing ... pores, causing breakouts, and threatening skin with unsightly acne scars. ... from Men’s Health on how to reduce and ...
Breaking Biology Technology:Syngenta Opens Unique $72 Million Advanced Crop Lab 2Syngenta Opens Unique $72 Million Advanced Crop Lab 3Cellular Biomedicine Group Achieves 50% Enrollment Milestone in Phase I Clinical Trial for Knee Osteoarthritis 2Aridis Pharmaceuticals Announces Acquisition of Monoclonal Antibody Products and Technologies From Kenta Biotech 2Aridis Pharmaceuticals Announces Acquisition of Monoclonal Antibody Products and Technologies From Kenta Biotech 3Adult Acne Treatment, Probiotic Action Shares New Insight on Why Men’s Skin Scars from Acne and How to Prevent It 2
... - Diagnostic Imaging,International Corp. (OTCBB: DIIG) announced today ... acquire Canadian Teleradiology Services,(CTS)., CTS specializes in ... and X-rays. This service allows hospitals in remote ... 24hrs per day. In,large population centers, CTS can ...
... Exceeds Expectations, MEMPHIS, Tenn., Nov. 10 ... focused on oncology, announced today that its,third ... the company continues,to experience banner growth. "The ... consistently exceed client expectations, and we are,ahead ...
... Pharma, Inc., a,diversified specialty pharmaceutical company, announced ... issues in the treatment of moderate to,severe ... dry eye medication Lacrisert(R),(hydroxypropyl cellulose ophthalmic insert), ... helps to retain,moisture, stabilize the tear film, ...
Cached Biology Technology:Diagnostic Imaging - Enters Purchase Agreement to Acquire Teleradiology Company 2ACORN CRO Continues Growth in Strong Third Quarter 2Dry Eye Survey: Ophthalmologists Cite Treatment Limitations/Gaps in Treatment of Moderate to Severe Dry Eye 2Dry Eye Survey: Ophthalmologists Cite Treatment Limitations/Gaps in Treatment of Moderate to Severe Dry Eye 3Dry Eye Survey: Ophthalmologists Cite Treatment Limitations/Gaps in Treatment of Moderate to Severe Dry Eye 4Dry Eye Survey: Ophthalmologists Cite Treatment Limitations/Gaps in Treatment of Moderate to Severe Dry Eye 5
(Date:5/16/2013)... Access to Research Careers) Program has announced the ... 95th Annual Meeting in San Francisco, CA from ... promote the entry of students, postdoctorates and scientists ... basic science community and to encourage the participation ... Meeting. , Awards are given to poster/platform presenters ...
(Date:5/16/2013)... at MIT may someday eliminate the need for ... their blood-sugar levels and inject themselves with insulin. ... levels in the body and respond by secreting ... function of pancreatic islet cells, which are destroyed ... type of system could ensure that blood-sugar levels ...
(Date:5/16/2013)... has discovered an ancient extinct creature with ,scissor hand-like, ... honour of his favourite movie star. , The ... (pronounced Koo-ten-ee-che-la depp-eye), which is a distant ancestor ... Johnny Depp for his starring role as Edward Scissorhands ... an unfinished creation, who has scissors for hands. ...
Breaking Biology News(10 mins):Nanotechnology could help fight diabetes 2Nanotechnology could help fight diabetes 3Actor Johnny Depp immortalized in ancient fossil find 2
... been listed as impaired by the state due to high counts ... in the late 1990s, but from whom, what and where the ... are located in a landscape that is predominately rural and agricultural, ... E. coli are livestock related, said Dr. June Wolfe, ...
... engineers at Johns Hopkins have developed a new liquid material ... in restoring damaged soft tissue relatively safely and durably. The ... under the skin, then "set" using light to form a ... a mold. The researchers say the product one day could ...
... amassed the largest data set to date on greenhouse ... in the online version of Nature Geoscience, ... the carbon dioxide and methane previously attributed to them. ... cautioned that hydroelectric reservoirs could be a significant and ...
Cached Biology News:AgriLife Research 'genetically fingerprinting' E. coli from watersheds 2AgriLife Research 'genetically fingerprinting' E. coli from watersheds 3AgriLife Research 'genetically fingerprinting' E. coli from watersheds 4New composite material may restore damaged soft tissue 2New composite material may restore damaged soft tissue 3Greenhouse gas impact of hydroelectric reservoirs downgraded 2
Fluorescein isothiocyanate (FITC) mouse anti-human IFN-alpha2 25 tests...
Dog polyclonal to Porcine Pancreatic Islets of Langerhans Cells ( Abpromise for all tested applications). Antigen: Tissue / cell preparation (Pig): Sonicated crude membrane fraction of porcine p...
Rabbit Anti-melatonin (different linkage) Polyclonal Antibody...
Anti-Cohesin (Scc1/Rad21) Monoclonal Antibody Research Focus: signal transduction Storage: -20C Shipping Temperature: +4C...
Biology Products: